Zymeworks (ZYME) Consolidated Net Income (2021 - 2026)

Zymeworks' (ZYME) quarterly Consolidated Net Income came in at -$44.2 million in Q1 2026, down 95.1% year-on-year from -$900.6 million in Q1 2025, and down 7.17% quarter-over-quarter from -$41.2 million in Q4 2025.

Zymeworks (ZYME) Consolidated Net Income (2021 - 2026) Analysis & Trends

Zymeworks has disclosed Consolidated Net Income across 6 years of filings, most recently posting -$44.2 million for Q1 2026.

  • Consolidated Net Income for Q1 2026 came in at -$44.2 million, down 95.1% year-over-year; the trailing twelve-month figure through Mar 2026 was -$102.7 million (up 9.7% YoY), and the FY2025 annual result was -$81.1 million, up 33.88% from the prior year.
  • Consolidated Net Income came in at -$44.2 million for Q1 2026 at Zymeworks, down from -$41.2 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $309.4 million in Q4 2022 to a low of -$72.6 million in Q1 2022.
  • The 5-year median for Consolidated Net Income is -$29.8 million (2024), against an average of -$14.3 million.
  • Across the five-year window, Consolidated Net Income surged 890.33% in 2022 and plunged 104.68% in 2023, its largest moves.
  • Zymeworks' Consolidated Net Income stood at $309.4 million in 2022, then slumped by 104.68% to -$14.5 million in 2023, then tumbled by 62.31% to -$23.5 million in 2024, then slumped by 75.31% to -$41.2 million in 2025, then fell by 7.17% to -$44.2 million in 2026.
  • The last three Consolidated Net Income figures came in at -$44.2 million (Q1 2026), -$41.2 million (Q4 2025), and -$19.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 30.80 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.40 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -14.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.96 Bn 91.96 Bn - -56.48 Mn
10 Zymeworks 1.73 Bn 1.36 Bn - -44.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -44.16 Mn
Dec 31, 2025 -41.21 Mn
Sep 30, 2025 -19.60 Mn
Jun 30, 2025 2.32 Mn
Mar 31, 2025 -22.64 Mn
Dec 31, 2024 -23.51 Mn
Sep 30, 2024 -29.85 Mn
Jun 30, 2024 -37.69 Mn
Mar 31, 2024 -31.65 Mn
Dec 31, 2023 -14.48 Mn
Sep 30, 2023 -28.69 Mn
Jun 30, 2023 -51.15 Mn
Mar 31, 2023 -24.35 Mn
Dec 31, 2022 309.43 Mn
Sep 30, 2022 -47.85 Mn
Jun 30, 2022 -64.62 Mn
Mar 31, 2022 -72.63 Mn
Dec 31, 2021 -39.15 Mn
Sep 30, 2021 -60.58 Mn